Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Visiongain Reports | The Global Vaccines Market 2008-2023

The Global Vaccines Market 2008-2023

The period 2008-2023 will see a vaccine “boost”. There will be a new resurgence in the sales and utilisation of vaccines. Are you prepared for this? You should be.

During this period, vaccines will be one of the fastest growing segments of the pharmaceutical market. Vaccine revenues will increase in size by several hundred percent between 2007 and 2023. This brand new in-depth report The Global Vaccines Market, 2008-2023 describes trends in the market both quantitatively and qualitatively. In recent years, this global vaccines market has undergone a renaissance, as the importance of vaccines in both developed and developing nations becomes underlined by epidemiological patterns and healthcare needs.

The key growth driver for vaccines is their cost-effectiveness in combating disease. This situation will encourage greater use of vaccines by governments and private healthcare providers. New disease targets that could be mitigated through vaccination, including high profile (and potentially profitable) targets such as cancer. Visiongain notes that many healthcare providers are viewing preventative medicine enthusiastically, being aware of the significant increases in quality of life and reduction of healthcare expenditure that can result from prophylaxis. The vaccines industry is responding with innovative products, making full use of technological advances in biotechnology. This market has great developmental potential, both therapeutically and commercially. There are currently more than 1000 vaccines in research and development worldwide.

In particular, The Global Vaccines Market, 2008-2023 concentrates on the following essential aspects of the vaccine industry:

• Sales forecasts for vaccines by disease area, brand and country, including novel therapeutic vaccines

• Examination of strengths, weakness, opportunities and threats facing the vaccine industry

• Expert opinion from key-opinion leaders in the field

• In-depth analysis of the vaccine pipeline

• Analysis of the prospects for therapeutic vaccines

• Geographical breakdown of the vaccine market, including the leading emerging markets of China and India

• Coverage of future trends in vaccine technology, formulation and manufacturing

• Identification of key industrial players in the vaccines market.

The Global Vaccines Market, 2008-2023 examines the vaccines market comprehensively, using unique primary and secondary research. The report includes full transcripts of interview – you cannot get this information anywhere else.

Also included are company reports, filings and industry databases. Exclusively, visiongain have applied their in-house analytical techniques for financial forecasting and analysis of drivers and restraints. Now available to you this comprehensive market-based report with detailed analyses, forecasts and informed opinion is essential to your vaccine market development.

Therapeutic vaccines differ from currently-marketed vaccines. Instead of simply preventing infection from disease, therapeutic vaccines work with the body’s immune system to fight diseases and disorders, including cancer, addiction and allergies. Their therapeutic and commercial potential is vast. Visiongain predicts that therapeutic vaccines will significantly expand the market for vaccines, contributing to rapid revenue growth during the period 2008 to 2023.

Why you should buy this report:

• To receive a comprehensive analysis of the prospects for vaccines, including key metrics and predicted revenues, by vaccine disease area and leading brand

• To receive forecasts of vaccine sales in leading country markets from 2008-2023, including China and India

• To discover the views of experts in the vaccines sector

• To determine the forces that influence the market for vaccines: drivers, restraints, opportunities and threats

• To find out where the vaccines market is heading - both technologically and commercially from 2008 to 2023.

Pricing:

Single user - password protected costs $2995.00

Departmental copies (this entitles up to 5 individual users in your department) of this report are available for only

USD 5995. This is not suitable for library usage.

Allow your whole company to have access to this information for only USD 9,995. Company-wide License allows your whole company access and intranet use on CD Rom and .pdf. Suitable for library storage and use.

Does your company have over 2,500 employees? Have the whole company access this information for a special rate of only USD 13,995

Publication date: 01/09/2008

Number of Pages: 196

PDF Formet
Table of Contents

License

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions